[144] United Therapeutics Corp SEC Filing

Rhea-AI Filing Summary

United Therapeutics insider filed a Form 144 to sell 112,500 shares of common stock on 09/02/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The filing lists an aggregate market value of $34,285,500.00 and reports 45,226,262 shares outstanding. The shares were acquired the same day, 09/02/2025, by exercise of stock options and paid in cash. No securities were reported sold by the person in the prior three months, and the filer represents they have no undisclosed material adverse information.

Positive

• Filer provided required Rule 144 disclosure including broker, share count, acquisition method, and representation regarding material information
• No sales reported in the prior three months for the selling person, indicating this is a single disclosed transaction

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider exercised options and intends to sell 112,500 shares worth $34.3M; routine disclosure with limited standalone market impact.

The filing shows a single transaction: exercise of stock options and proposed sale of 112,500 common shares on 09/02/2025 through Morgan Stanley Smith Barney LLC at an aggregate market value of $34,285,500. The filing reports 45,226,262 shares outstanding, providing context for scale. There are no reported sales by the person in the prior three months. This is a standard Rule 144 notice documenting a proposed sale rather than financial results or new corporate actions. From the filing alone, there is no additional operational or financial information disclosed.

Corporate Governance Expert

TL;DR: The disclosure complies with Rule 144 reporting for an insider option exercise and sale; it includes the required representations and signatures.

The Form 144 contains the necessary elements: issuer and broker identification, class of securities, number of shares (112,500), acquisition method (exercise of stock options on 09/02/2025), payment in cash, and the filer’s representation about material non-public information. The filing notes no aggregated sales in the past three months. Based solely on the document, this is a routine compliance filing without governance changes or additional disclosures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	112500	34285500.00	45226262	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Exercise of Stock Options	Issuer			112500	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the UTHR Form 144?

The filing reports a proposed sale of 112,500 common shares acquired by exercise of stock options on 09/02/2025, to be sold via Morgan Stanley Smith Barney LLC on NASDAQ.

How much is the aggregate market value of the shares in the filing?

The aggregate market value is reported as $34,285,500.00.

When were the shares acquired and how were they paid for?

The shares were acquired on 09/02/2025 through the exercise of stock options and payment was made in cash on the same date.

Does the filing show other recent sales by the same person?

No. The section for securities sold during the past three months states: Nothing to Report.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.